A statement released earlier today by Peel Hunt about Vectura Group PLC (LON:VEC) maintains the target price at 200.00GBX
- Updated: November 26, 2016
Boasting a price of 0.00GBX, Vectura Group PLC (LON:VEC) traded 0.47% higher on the day. With the last stock price close down 1.46% from the two hundred day average, compared with the S&P 500 Index which has decreased -0.03% over the date range. Vectura Group PLC has recorded a 50-day average of 138.63GBX and a two hundred day average of 147.84GBX. Volume of trade was down over the average, with 1,454,654 shares of VEC changing hands under the typical 1,796,180
Peel Hunt hold steady the target of Vectura Group PLC (LON:VEC) at 200.00GBX stating a potential upside of 0%.
On 11/22/2016, N+1 Singer released a statement for Vectura Group PLC (LON:VEC) maintained the target price at 208.00GBX that suggested an upside of 0.40%.
With a total market value of 0 GBX, Vectura Group PLC has price-earnings ratio of 125.00 with a one year low of 122.90GBX and a one year high of 200.10GBX .
A total of 6 equity analysts have released a research note on VEC. Four equity analysts rating the company a strong buy, two equity analysts rating the company a buy, one equity analyst rating the company a hold, zero equity analysts rating the company a underperform, and finally zero equity analysts rating the company a sell with a one year target of 215.67GBX.
More About Vectura Group PLC (LON:VEC)
Vectura Group plc is engaged in research, development and commercialization of therapeutic products and drug delivery systems for human use. The Company's products include Ultibro Breezhaler (European Union (EU) and Rest of World (RoW)) – LABA-LAMA; Seebri Breezhaler (EU and RoW) – LAMA; AirFluSal Forspiro (EU and RoW) – ICS-LABA; ADVATE (Global) – Antihaemophilic Factor (Recombinant); Adept (Global) – Icodextrin; Anoro Ellipta (Global) – LAMA-LABA; Relvar Ellipta/Breo Ellipta (Global) – ICS-LABA, and Incruse Ellipta (Global) – LAMA. Its product pipeline includes VR588, VR475, VR647, VR942, VR179, VR736, VR096, VR876, VR315, VR506, VR632, Seebri Neohaler and VR465. Its dry powder inhalers (DPI) include GyroHaler, Lever-operated, Open-inhale-close and Unit Dose DPI. Its smart nebuliser delivery systems provide targeted inhalation therapy for applications where precise and targeted delivery of a drug to the lungs is needed. Its smart nebulizer delivery systems include AKITA JET and FOX.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.